High-Level Production of Recombinant Human Parathyroid Hormone 1-34

AUTOR(ES)

Suzuki, Yuji

FONTE

American Society for Microbiology

RESUMO

Expression of the synthetic human parathyroid hormone 1-34 [hPTH(1-34)] gene by a gene fusion strategy was demonstrated. hPTH(1-34) was produced at the C terminus of the partner peptides involving amino acids 1 to 97, 1 to 117, or 1 to 139 of a modified Escherichia coli β-galactosidase by linker peptides containing oligohistidine of different lengths. The fusion proteins in the inclusion bodies were rendered soluble with urea and subjected to site-specific cleavage with the secretory type yeast Kex2 protease. Optimal expression and enzymatic processing were achieved in the fusion protein βG-117S4HPT, constructed from amino acids 1 to 117 of β-galactosidase and the linker of HHHHPGGSVKKR. The fusion protein accumulated more than 20% of the E. coli total protein. The hPTH(1-34) was purified up to 99.5% with a good yield of 0.5 g/liter of culture. The purified product was identified as intact hPTH(1-34) by amino acid analysis and N-terminal sequencing.

Documentos Relacionados

• Comparison of postreceptor effects of 1-34 human hypercalcemia factor and 1-34 human parathyroid hormone in rat osteosarcoma cells.
• Human Parathyroid Hormone: Amino-Acid Sequence of the Amino-Terminal Residues 1-34
• High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells
• High-level production of biologically active human alpha 1-antitrypsin in Escherichia coli.
• Ping-pong amplification of a retroviral vector achieves high-level gene expression: human growth hormone production.